Research shows that certain racial/ethnic groups and individuals with lower income levels are at a heightened risk of developing diabetes and diabetes-related complications.
Suboxone, a combination of buprenorphine and naloxone, relieves cravings and withdrawal symptoms and substantially reduces opioid use disorder–related mortality.
As a classwide effect, these medications have been shown to reduce the composite of hospitalizations and cardiovascular death in patients with preserved ejection fraction.
The American College of Rheumatology has updated its recommendations for treatment with nonsteroidal anti-inflammatory drugs, duloxetine, opioids, glucosamine, and chondroitin.